Celsion remains a comparatively undiscovered story which will change rapidly post the 190 event announcement and even more rapidly after FDA approval. If as that path is travelled, a major Private Equity firm makes a PIPE investment in the Company, the stock will likely trade in the $10-$30 range depending exactly what stage the Company is at when the PIPE investment is made. I intend to start seeking to make these introductions immediately.
...all well and good, but right now this "gem" is trading at $2.91, down roughly 30% from it's highs despite some good news and supposedly good earnings call.
It looks like this thing has gotten the attention of some very rabid hedgies. I don't see this going any further. Business as usual in America. Destroy anything that even remotely looks promising--sacrifice it to the Gods of Greed that have become Wall Street and status quo power in this country now.
It is too thin a trader for all but the most suicidal hedgies. But otherwise, I share your feelings. This stock belongs in the hands of genuinely dedicated medical foundation style funds who do have humanity at the heart of their investment style. Fortunately, I know several very well and I am going to encourage them to accumulate the stock gradually in the open market.